Genetic Predisposition for Type 2 Diabetes, but Not for Overweight/Obesity, Is Associated with a Restricted Adipogenesis
Open accessThe DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Development of Type 2 diabetes, like obesity, is promoted by a genetic predisposition. Although several genetic variants have been identified they only account for a small proportion of risk. We have asked if genetic risk is associated with abnormalities in storing excess lipids in the abdominal subcutaneous adipose tissue. METHODOLOGY/PRINCIPAL FINDINGS: We recruited 164 lean and 500 overweight/obese individuals with or without a genetic predisposition for Type 2 diabetes or obesity. Adipose cell size was measured in biopsies from the abdominal adipose tissue as well as insulin sensitivity (HOMA index), HDL-cholesterol and Apo AI and Apo B. 166 additional non-obese individuals with a genetic predisposition for Type 2 diabetes underwent a euglycemic hyperinsulinemic clamp to measure insulin sensitivity. Genetic predisposition for Type 2 diabetes, but not for overweight/obesity, was associated with inappropriate expansion of the adipose cells, reduced insulin sensitivity and a more proatherogenic lipid profile in non-obese individuals. However, obesity per se induced a similar expansion of adipose cells and dysmetabolic state irrespective of genetic predisposition. CONCLUSIONS/SIGNIFICANCE: Genetic predisposition for Type 2 diabetes, but not obesity, is associated with an impaired ability to recruit new adipose cells to store excess lipids in the subcutaneous adipose tissue, thereby promoting ectopic lipid deposition. This becomes particularly evident in non-obese individuals since obesity per se promotes a dysmetabolic state irrespective of genetic predisposition. These results identify a novel susceptibility factor making individuals with a genetic predisposition for Type 2 diabetes particularly sensitive to the environment and caloric excess.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“It has been shown that nonobese subjects with type 2 diabetes mellitus (T2D) and nondiabetic subjects with a genetic predisposition for T2D (first-degree relatives: FDR) have an unwarranted hypertrophic expansion of subcutaneous adipose tissue (SAT) [10].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [10]
Experimental — accuracy not yet measuredIn the citing paper
“These two patterns appear tightly entwined: the link between obesity and adipose cell size is undoubtedly curvilinear, and as numerous elegant investigations have been demonstrated in studies [8,9,10], the formation of new adipocytes is triggered when the increase in adipocyte size arrives at a plateau [7].”
From Adipose Tissue: A Novel Target of the Incretin Axis? A Paradigm Shift in Obesity-Linked Insulin Resistance (2024) · cites this paper as [10]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502 · cited 1×
“Blood samples were drawn for measurements of fasting lipids, glucose and insulin levels as reported [6,16] and HOMA index, which is an indirect measure of insulin sensitivity, was calculated [18].”
MethodObesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“secretion of adipokines including reduced adiponectin levels and local infiltration of inflammatory cells which inhibits normal adipogenesis and differentiation of preadipocytes [9–12].”
BackgroundGlobal and societal implications of the diabetes epidemic
Zimmet, P., Alberti, K. G. M. M., & Shaw, J. (2001) · Nature · doi:10.1038/414782a · Cited by 5,883 · cited 1×
“Type 2 diabetes is undergoing a global epidemic mainly driven by a concomitant epidemic in obesity [1].”
BackgroundAbdominal obesity and metabolic syndrome
Després, J.-P., & Lemieux, I. (2006) · Nature · doi:10.1038/nature05488 · Cited by 4,354 · cited 2×
“The expanded adipose tissue mass in obesity promotes insulin resistance which, in turn, induces Type 2 diabetes in genetically susceptible individuals [2,3].”
BackgroundDynamics of fat cell turnover in humans
Spalding, K. L., Arner, E., Westermark, P. O., Bernard, S., Buchholz, B. A., Bergmann, O., Blomqvist, L., Hoffstedt, J., Näslund, E., Britton, T., et al. (2008) · Nature · doi:10.1038/nature06902 · Cited by 2,357 · cited 1×
“[7] recently showed that the number of abdominal subcutaneous adipose cells becomes established around puberty and that adipose cell expansion becomes the predominant event for subsequent fat accumulation.”
BackgroundSelf-citationKrotkiewski, M., Björntorp, P., Sjöström, L., & Smith, U. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111040 · Cited by 1,456 · cited 6×
“Accumulation of excess lipids in the adipose tissue can, in principle, be induced by an expansion of the number of differentiated adipose cells (hyperplastic obesity) and/or by adipose cell enlargement (hypertrophic obesity) [5,6].”
BackgroundMethodInfluentialSelf-citationGlucose Transporters and Insulin Action — Implications for Insulin Resistance and Diabetes Mellitus
Shepherd, P. R., & Kahn, B. B. (1999) · New England Journal of Medicine · doi:10.1056/nejm199907223410406 · Cited by 1,295 · cited 1×
“This was initially described in patients with Type 2 diabetes [13,14], but is now well established to precede the development of Type 2 diabetes and to be associated with insulin resistance and a dysmetabolic state also in non-obese individuals [10,11,15].”
BackgroundClinical risk factors, DNA variants, and the development of type 2 diabetes
Lyssenko, V., Jonsson, A., Almgren, P., Pulizzi, N., Isomaa, B., Tuomi, T., Berglund, G., Altshuler, D., Nilsson, P., & Groop, L. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801869 · Cited by 938
Weyer, C., Foley, J. E., Bogardus, C., Tataranni, P. A., & Pratley, R. E. (2000) · Diabetologia · doi:10.1007/s001250051560 · Cited by 799 · cited 13×
“Individuals with a genetic predisposition for a high BMI showed no evidence of an inappropriate expansion of cell size in relation to amount of body fat measured as delta-value (Table 1).”
ResultInfluentialAdipocyte Turnover: Relevance to Human Adipose Tissue Morphology
Arner, E., Westermark, P. O., Spalding, K. L., Britton, T., Rydén, M., Frisén, J., Bernard, S., & Arner, P. (2010) · Diabetes · doi:10.2337/db09-0942 · Cited by 645
Self-citationRegional differences in cellular mechanisms of adipose tissue gain with overfeeding
Tchoukalova, Y. D., Votruba, S. B., Tchkonia, T., Giorgadze, N., Kirkland, J. L., & Jensen, M. D. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1005259107 · Cited by 378 · cited 1×
“However, adult women may still recruit new cells in the femoral/gluteal depot which appears to counteract abdominal adipocyte accumulation [8] and this may contribute to the well-established finding that peripheral (gluteofemoral) obesity is less harmful than abdominal obesity [5,6].”
BackgroundImpaired Preadipocyte Differentiation in Human Abdominal Obesity
Isakson, P., Hammarstedt, A., Gustafson, B., & Smith, U. (2009) · Diabetes · doi:10.2337/db08-1770 · Cited by 369
Self-citationRondinone, C. M., Wang, L.-M., Lonnroth, P., Wesslau, C., Pierce, J. H., & Smith, U. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.4171 · Cited by 298
Self-citationGustafson, B., & Smith, U. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m512077200 · Cited by 261 · cited 1×
“TNFa would appear as an interesting candidate since it is a powerful inhibitor of differentiation of human preadipocytes [12] and, in addition, activates Wnt signaling [21].”
BackgroundSelf-citationSmith, U. (2002) · International Journal of Obesity · doi:10.1038/sj.ijo.0802028 · Cited by 209 · cited 2×
“Also other markers of a dysregulated adipose tissue, including markers of terminal cell differentiation and PPARcregulated genes such as adiponectin and GLUT4, are commonly reduced in the abdominal adipose tissue in individuals with a genetic predisposition for Type 2 diabetes [10,11,15].”
BackgroundSelf-citationAdipocyte size predicts incidence of type 2 diabetes in women
Lönn, M., Mehlig, K., Bengtsson, C., & Lissner, L. (2010) · The FASEB Journal · doi:10.1096/fj.09-133058 · Cited by 207 · cited 13×
“Individuals with a genetic predisposition for a high BMI showed no evidence of an inappropriate expansion of cell size in relation to amount of body fat measured as delta-value (Table 1).”
ResultInfluentialLaakso, M., Zilinskaite, J., Hansen, T. F., Boesgaard, T. W., Vänttinen, M., Stančáková, A., Jansson, P., Pellmé, F., Holst, J. J., Kuulasmaa, T., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0899-2 · Cited by 158 · cited 3×
“166 individuals with at least one known first-degree relative with Type 2 diabetes were recruited in Gothenburg and phenotyped as described [16].”
BackgroundMethodSelf-citationCarvalho, E., Jansson, P., Nagaev, I., Wenthzel, A., & Smith, U. (2001) · The FASEB Journal · doi:10.1096/fsb2fj000435 · Cited by 139 · cited 4×
“Also other markers of a dysregulated adipose tissue, including markers of terminal cell differentiation and PPARcregulated genes such as adiponectin and GLUT4, are commonly reduced in the abdominal adipose tissue in individuals with a genetic predisposition for Type 2 diabetes [10,11,15].”
BackgroundResultSelf-citationJansson, P.-A., Pellmé, F., Hammarstedt, A., Sandqvist, M., Brekke, H., Caidahl, K., Forsberg, M., Volkmann, R., Carvalho, E., Funahashi, T., et al. (2003) · The FASEB Journal · doi:10.1096/fj.02-1132com · Cited by 117 · cited 4×
“Also other markers of a dysregulated adipose tissue, including markers of terminal cell differentiation and PPARcregulated genes such as adiponectin and GLUT4, are commonly reduced in the abdominal adipose tissue in individuals with a genetic predisposition for Type 2 diabetes [10,11,15].”
BackgroundResultSelf-citationSerino, M., Menghini, R., Fiorentino, L., Amoruso, R., Mauriello, A., Lauro, D., Sbraccia, P., Hribal, M. L., Lauro, R., & Federici, M. (2007) · Diabetes · doi:10.2337/db07-0360 · Cited by 113
Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives
Hellström, L., Langin, D., Reynisdottir, S., Dauzats, M., & Arner, P. (1996) · Diabetologia · doi:10.1007/bf00403911 · Cited by 83 · cited 1×
“Family history for overweight/obesity or Type 2 diabetes was determined as described [17].”
BackgroundSelf-citationAdipocyte Turnover: Relevance to Human Adipose Tissue
Arner, M., Westermark, P. O., Spalding, K. L., Britton, T., Bernard, S., & Arner, P. (2010) · Cited by 12
Self-citationObesity and risk of myocardial infarction: the INTERHEART study
Wilding, J. P. H., & Finer, N. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68463-8 · Cited by 7
Cited by
Adapting to obesity with adipose tissue inflammation
Reilly, S. M., & Saltiel, A. R. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2017.90 · Cited by 1,204
The science of obesity management: an endocrine society scientific statement
Bray, G. A., Heisel, W. E., Afshin, A., Jensen, M. D., Dietz, W. H., Long, M., Kushner, R. F., Daniels, S. R., Wadden, T. A., Tsai, A. G., et al. (2018) · Endocrine Reviews · doi:10.1210/er.2017-00253 · Cited by 812
The aetiology and molecular landscape of insulin resistance
James, D. E., Stöckli, J., & Birnbaum, M. J. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00390-6 · Cited by 690
Causes, Characteristics, and Consequences of Metabolically Unhealthy Normal Weight in Humans
Stefan, N., Schick, F., & Häring, H.-U. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.07.008 · Cited by 575
The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
Saponaro, C., Gaggini, M., Carli, F., & Gastaldelli, A. (2015) · Nutrients · doi:10.3390/nu7115475 · Cited by 529
“Non-obese individuals at risk of T2DM are more prone to develop an obese phenotype with dysregulated adipose tissue, hypertrophic enlargement of adipocytes and reduced circulating adiponectin levels and glucose transporter-4 (GLUT4) expression for glucose uptake [89].”
Background
Metadata
- Authors
- Arner, P., Arner, E., Hammarstedt, A., & Smith, U.
- Affiliations
- Karolinska Institutet (SE)
- University of Gothenburg (SE)
- Corresponding author
- Smith, Ulf
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-04-12
- Volume
- 6
- Issue
- 4
- Pages
- e18284
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3075240
- OpenAlex
- W2013246050
- Cited by
- 146
- References
- 23
- Citations by year
- 2026: 2 · 2025: 11 · 2024: 8 · 2023: 5 · 2022: 17 · 2021: 8 · 2020: 7 · 2019: 5 · 2018: 8 · 2017: 14 · 2016: 6 · 2015: 16 · 2014: 10 · 2013: 14 · 2012: 13
- FWCI
- 9.40
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Karolinska Institutet
- Novo Nordisk
- Vetenskapsrådet
- Novo Nordisk Fonden
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- type 2 diabetes, genetic susceptibility, obesity, adipogenesis, insulin sensitivity, subcutaneous abdominal fat, ectopic fat deposition, dysmetabolic syndrome, atherosclerosis risk, caloric excess
- MeSH terms
- Adipose Tissue, Diabetes Mellitus, Type 2, Humans, Obesity, Genetic Predisposition to Disease, Overweight
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.